Tapestry Announces Strategy to Focus on TPI 287 Clinical Program
“We continue to recruit patients for TPI 287's prostate and pancreatic cancer trials and we are moving forward with plans to initiate several other, previously announced studies”
Tapestry Pharmaceuticals, Inc. , announced today a plan to focus all of its resources on advancing TPI 287's on-going and previously announced clinical trials. via Med Ad News
Join the discussion below, or Read more at Med Ad News.
#1 Oct 26, 2007
It's sad state of affairs when promising drugs can not be developed because of some legalese. Is that what our society has progress too, better yet, digress or degraded too. If that is the case, let me die under the Mango Tree during a Tomumbo.
Add your comments below
|Gingrich's 1st divorce: still oft-told, varied ... (Nov '11)||May '16||LBGT||27|
|fda approves viagra rival from drug maker vivus (Apr '16)||Apr '16||Woods||1|
|Americans: How health care law affected them (Nov '14)||Nov '14||Not Cool||1|
|NM attorney general: 'Right to die' ruling may ... (Jan '14)||Jan '14||Lobo Viejo||14|
|Official: 'Right to die' ruling may face appeal (Jan '14)||Jan '14||Good||11|
|Health: A fresh approach to cancer, plus keep a... (Nov '13)||Nov '13||jjsalon||1|
|Health risks fade when women quit estrogen (Apr '11)||Oct '13||Miya Allen||3|
Find what you want!
Search Uterine Cancer Forum Now
Copyright © 2016 Topix LLC